French-based biotech giant Aventis is due to tell a US Environmental Protection Agency panel this week that trace amounts of its much-maligned GM corn StarLink corn pose no threat to the US food supply.
StarLink, which had been sold in the US for three years, was pulled from the market over fears that it could cause an allergic reaction in human consumers. The corn was approved for use in livestock feed, but Aventis agreed to buy the 2000 crop back from farmers after mass recalls when food products became contaminated.
The EPA panel ruled in December that there existed a “low probability” that trace amounts of the corn would cause an allergic reaction. Nevertheless it found that there is a “medium likelihood” that allergic reactions would be sparked by the corn, and that children were more likely to experience reactions.
In a bid to prevent the upheaval of further product recalls due to trace elements of StarLink, Aventis is to tell the EPA that minute amounts of the corn do not pose a threat to consumers’ health.
To view related research reports, please follow the links below:- World Agricultural Biotechnology: GMOs to 2004 How well do you really know your competitors?Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Company Profile – free
sample
Thank you!Your download email will arrive shortly Not ready to buy yet? Download a free sampleWe are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form By GlobalDataHandbook on the Labelling of Genetically Modified Foods, Ingredients and Additives |